8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________________________________________

FORM 8-K

__________________________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 30, 2022

__________________________________________________________

HEALTH CATALYST, INC.

(Exact name of registrant as specified in its charter)

________________________________________________________________

Delaware	001-38993	45-3337483
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

10897 South River Front Parkway #300

South Jordan, UT 84095

(Address of principal executive offices, including zip code)

(801) 708-6800

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

______________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

______________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of exchange on which registered
Common Stock, par value $0.001 per share	HCAT	The Nasdaq Global Select Market

________________________________________________________

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ((§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 30, 2022, Paul Horstmeier provided notice to Health Catalyst, Inc. (the “Company”) that he will step down from his position as Chief Operating Officer of the Company, effective March 31, 2023 (the “Separation Date”), due to Mr. Horstmeier being called by the leadership of the Church of Jesus Christ of Latter-Day Saints to serve for 3 years as Mission President of the Puerto Rico San Juan Mission, beginning in June 2023. Mr. Horstmeier’s departure is not the result of any disagreement or conflict with the Company. At the current time, Mr. Horstmeier’s responsibilities will transition to certain members of the Company’s leadership. To help ensure a smooth transition of his responsibilities, Mr. Horstmeier will continue to be employed by the Company on a full-time basis through the Separation Date and, thereafter, will support the Company as a senior advisor.

A copy of the press release issued by the Company on January 6, 2023 regarding the transition of Mr. Horstmeier is attached hereto as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.	Description
99.1	Press release issued by Health Catalyst, Inc. on January 6, 2023

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		HEALTH CATALYST, INC.
Date: January 6, 2023	By:	/s/ Bryan Hunt
		Bryan Hunt
		Chief Financial Officer

EX-99.1

Exhibit 99.1

Health Catalyst Announces New, External Leadership Assignment for Paul Horstmeier

Salt Lake City, UT – January 6, 2023 – Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that the leadership of the Church of Jesus Christ of Latter-Day Saints has called Paul Horstmeier, Health Catalyst’s Chief Operating Officer, to serve for three years as the Mission President of the Puerto Rico San Juan Mission, beginning in late June 2023.

As a result, Mr. Horstmeier will transition from his full-time position as Chief Operating Officer, effective March 31, 2023, to that of a Senior Advisor. Mr. Horstmeier will continue working closely with Dan Burton, CEO of Health Catalyst, to transition his responsibilities to other senior leaders at Health Catalyst in the coming months.

“Paul’s contributions to Health Catalyst’s growth and success over the past 11 ½ years have been enormous and deeply impactful,” said Mr. Burton. “Paul will be sorely missed as he and his wife Karryl serve the missionaries and people of Puerto Rico during their three-year tenure, but I have no doubt of the positive effect of their sacrifice and service, and we look forward to welcoming Paul back full-time to Health Catalyst after the conclusion of this mission assignment.”

This is the second time a member of Health Catalyst’s Senior Leadership Team has been called to serve as a Mission President for the Church of Jesus Christ of Latter-Day Saints. From 2017 to 2020, Health Catalyst Co-Founder Steve Barlow was called to serve as a Mission President in Ecuador, which necessitated his transition for three years, followed by his subsequent return to Health Catalyst in the fall of 2020. Health Catalyst, as a mission-driven organization, is grateful for and supportive of the many contributions its team members make in providing various types of volunteer service to the broader community.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its more than 500 clients leverage the cloud-based data platform or its other software applications—powered by data from over 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Media Contact:

Tarah Neujahr Bryan, Chief Marketing Officer

media@healthcatalyst.com

XML

Cover Page	Dec. 30, 2022
Entity Information [Line Items]
Document Type	8-K
Document Period End Date	Dec. 30, 2022
Entity Registrant Name	HEALTH CATALYST, INC.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-38993
Entity Tax Identification Number	45-3337483
Entity Address, Address Line One	10897 South River Front Parkway
Entity Address, Address Line Two	#300
Entity Address, City or Town	South Jordan
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84095
City Area Code	801
Local Phone Number	708-6800
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	HCAT
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false
Amendment Flag	false
Entity Central Index Key	0001636422
Former Address
Entity Information [Line Items]
Entity Address, Address Line One	Not Applicable